Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The RNA-binding protein fragile X-related 1 regulates somite formation in Xenopus laevis.
Huot ME
,
Bisson N
,
Davidovic L
,
Mazroui R
,
Labelle Y
,
Moss T
,
Khandjian EW
.
???displayArticle.abstract???
Fragile X-related 1 protein (FXR1P) is a member of a small family of RNA-binding proteins that includes the Fragile X mental retardation 1 protein (FMR1P) and the Fragile X-related 2 protein (FXR2P). These proteins are thought to transport mRNA and to control their translation. While FMR1P is highly expressed in neurons, substantial levels of FXR1P are found in striated muscles and heart, which are devoid of FMRP and FXR2P. However, little is known about the functions of FXR1P. We have isolated cDNAs for Xenopus Fxr1 and found that two specific splice variants are conserved in evolution. Knockdown of xFxr1p in Xenopus had highly muscle-specific effects, normal MyoD expression being disrupted, somitic myotomal cell rotation and segmentation being inhibited, and dermatome formation being abnormal. Consistent with the absence of the long muscle-specific xFxr1p isoform during early somite formation, these effects could be rescued by both the long and short mRNA variants. Microarray analyses showed that xFxr1p depletion affected the expression of 129 known genes of which 50% were implicated in muscle and nervous system formation. These studies shed significant new light on Fxr1p function(s).
Figure 1.
Expression of Fxr1p in mouse and frog. Immunoblot analyses of Fxr1p in selected tissues of adult mouse (left) and adult Xenopus (right). Antibody mAb3FX is directed against an epitope common to all Fxr1p isoforms from both mouse and frog, whereas #27-17 is directed against the 27-amino acid pocket coded by the exon 15 that also is present in Xenopus. Fmr1p is detected predominantly in brain extracts from both mouse and frog. Note the cross-reactivity between mAb1C3 and Fxr1p in mouse heart and muscle as described previously (Khandjian et al., 1998; Chemicon International information sheet, MAB2160). H, heart; B, brain; M, muscle; L, liver; and K, kidney.
Figure 2 Fxr1p is conserved in vertebrates. (a) Detection of xFxr1 mRNA variants by RT-PCR in different tissues from mouse and frog by using primers flanking the muscle-specific exon. Northern blots containing RNA isolated from murine and frog tissues (H, heart; B, brain; M, muscle; L, liver; and K, kidney) were hybridized with probes specific for mouse and frog Fxr1. The muscle sequence (exon 15) is found in both mouse and Xenopus. (b) Amino acid sequence of Xenopus Fxr1p (xFxr1p) aligned with human (hFXR1P), mouse (mFxr1p), and zebrafish (zFxr1p) sequences. Conserved amino acids are boxed in black, similar amino acids are in light gray and divergent amino acids are in white. (c) Representation of the mouse (m Iso a-g) and Xenopus (x Iso a and b) Fxr1 mRNA-spliced variants.
Figure 3. Nucleotide alignment of human, mouse, and frog 3′-UTR. (a) Short 3′-UTR. (b) Long 3′-UTR. Nucleotides are numbered according to Kirkpatrick et al. (1999) and GenBank accession no. U25165.
Figure 4. (a) Developmental profile of xFxr1p accumulation during the first stages of embryogenesis. β-tubulin was used as an internal marker. (b) Immunostained sections of a 12.5 dpc mouse embryo and stage 36 Xenopus embryos reacted with antibody #27-17-specific to the muscle-specific isoforms. Positive signals for Fxr1p were revealed with chromophore AEC (red staining). Counterstaining with hematoxylin (blue).
Figure 5. Morphological alterations induced in Xenopus embryos after injection of Fxr1.Morpholino (Fxr1.MO). (a) Lateral and dorsal views of control embryos for the diffusion of the fluorescein tagged Morpholino directed against the human globin (hGlob.MO) injected in one blastomere of two-cell stage embryos. (b) Injected embryos with xFxr1.MO mismatch (mm) as control, and with increasing concentrations of match MO. Number of injected embryos (n =) is on the right of each panel, as well as percentage of penetrance of the depicted phenotypes. The severity of morphological alterations is proportional to the concentration of injected Fxr1.MO (0.3-1.0 pmol). (c) Rescue of the phenotypes is dose-dependent of the injected HA.Fxr1 mRNA.
Figure 6. Biochemical evidence that xFxr1p levels decrease after xFxr1.MO treatment. (a) Coomassie-stained proteins after SDS-PAGE analysis of anterior and posterior extracts obtained from one embryo at stage 36 injected with 0.3 pmol of either xFxr1.MOmm (C, control) or xFxr1.MO (+MO). Western blot analysis using antibody mAb3FX for detection of xFxr1p, and antibodies to tubulin, actin, and ribosomal L7 proteins. (b) Partial inactivation of xFxr1correlates with decreased xFxr1p levels in the forming tail. Immunostaining view of a longitudinal section reacted with mAb3FX to detect Fxr1p. Note the reduced levels of xFxr1p in myotomes (arrows) as well as in the head (arrow head) in the injected side of the embryo.
Figure 7. Depletion of Fxr1p alters somite formation. (a) In situ hybridization showing the presence of the lateralxMyoD mRNA in the control side, whereas a reduction is observed in the injected side. xMyoD mRNA levels are restored after coinjection with HA.xFr1 mRNA. (b) Left, schematic overview of somite formation in Xenopus. Middle, disruption of nuclear alignment in the injected side of the same embryo depicted in a, as detected by Hoechst staining (right side). Right, somitic nuclei are realigned after rescue with xFxr1 mRNA (same embryo as in a).
Figure 8. Injection of 0.6 pmol of xFxr1.MO in both blastomeres at the two-cell stage induces alteration at stage 30. RNA extracted from the control and from the injected embryos were subjected to microarray analyses presented in Figure 7.
Figure 9.
Microarray analyses of injected embryos with 0.6 pmol of xFxr1.MO versus wild-type embryos. (a) The data set in the squatter plot shows the expression levels of genes on a logarithmic scale as the median value of uninjected (x-axis) and xFxr1.MO injected (y-axis) embryos. The threshold for significancy (p < 0.05) was set at 2.5-fold of change. (b) Examples of validation of RT-PCR analyses of stable (Fxr1), increased (XIRG), and decreased (MAP2, TTR, and MHC) mRNAs in knockdown experiments. (c) Percentage of up- and down-regulated transcripts. (d) Percentage of transcripts of unknown (EST) or known functions, and those presenting homologies to genes not yet described in Xenopus. (e) Tissue distribution of the 129 known transcripts (31.8% in Figure 8d) affected. Note that due to overlapping of these transcripts in different tissues the distribution is only relative and cannot be considered as absolute.
Antar,
Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
2004, Pubmed
Antar,
Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
2004,
Pubmed
Bakker,
Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse.
2000,
Pubmed
Bardoni,
Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes.
2002,
Pubmed
Bisson,
The catalytic domain of xPAK1 is sufficient to induce myosin II dependent in vivo cell fragmentation independently of other apoptotic events.
2003,
Pubmed
,
Xenbase
Bontekoe,
Knockout mouse model for Fxr2: a model for mental retardation.
2002,
Pubmed
Brunekreef,
Extralenticular expression of Xenopus laevis alpha-, beta-, and gamma-crystallin genes.
1997,
Pubmed
,
Xenbase
Corbin,
The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes.
1997,
Pubmed
Cox,
Cardiac myosin heavy chain expression during heart development in Xenopus laevis.
1995,
Pubmed
,
Xenbase
Coy,
Highly conserved 3' UTR and expression pattern of FXR1 points to a divergent gene regulation of FXR1 and FMR1.
1995,
Pubmed
Craft,
The arrestin superfamily: cone arrestins are a fourth family.
1995,
Pubmed
,
Xenbase
Cripe,
Vimentin mRNA location changes during muscle development.
1993,
Pubmed
De Diego Otero,
Transport of fragile X mental retardation protein via granules in neurites of PC12 cells.
2002,
Pubmed
Devys,
The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.
1993,
Pubmed
Dubé,
Muscle specific fragile X related protein 1 isoforms are sequestered in the nucleus of undifferentiated myoblast.
2000,
Pubmed
Eberhart,
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals.
1996,
Pubmed
Engels,
Characterization of Fxr1 in Danio rerio; a simple vertebrate model to study costamere development.
2004,
Pubmed
Fulton,
Organization of protein and mRNA for titin and other myofibril components during myofibrillogenesis in cultured chicken skeletal muscle.
1997,
Pubmed
Garnon,
Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level.
2005,
Pubmed
Hamilton,
The formation of somites in Xenopus.
1969,
Pubmed
,
Xenbase
Heasman,
Morpholino oligos: making sense of antisense?
2002,
Pubmed
,
Xenbase
Hemmati-Brivanlou,
Localization of specific mRNAs in Xenopus embryos by whole-mount in situ hybridization.
1990,
Pubmed
,
Xenbase
Huot,
Developmental expression of the fragile X-related 1 proteins in mouse testis: association with microtubule elements.
2001,
Pubmed
Jockusch,
From the nucleus toward the cell periphery: a guided tour for mRNAs.
2003,
Pubmed
Jowett,
Whole-mount in situ hybridizations on zebrafish embryos using a mixture of digoxigenin- and fluorescein-labelled probes.
1994,
Pubmed
Khandjian,
Biology of the fragile X mental retardation protein, an RNA-binding protein.
1999,
Pubmed
Khandjian,
A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture.
1995,
Pubmed
Khandjian,
Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis.
1998,
Pubmed
Khandjian,
UV crosslinking of RNA to nylon membrane enhances hybridization signals.
1986,
Pubmed
Kirkpatrick,
Alternative splicing in the murine and human FXR1 genes.
1999,
Pubmed
,
Xenbase
Klein,
The first cleavage furrow demarcates the dorsal-ventral axis in Xenopus embryos.
1987,
Pubmed
,
Xenbase
Kumasaka,
Isolation and developmental expression of tyrosinase family genes in Xenopus laevis.
2003,
Pubmed
,
Xenbase
Laggerbauer,
Evidence that fragile X mental retardation protein is a negative regulator of translation.
2001,
Pubmed
,
Xenbase
Latinkic,
Transcriptional regulation of the cardiac-specific MLC2 gene during Xenopus embryonic development.
2004,
Pubmed
,
Xenbase
Lhuillier,
Influence of muscle cells on the development of calcium currents in Xenopus spinal neurons.
1998,
Pubmed
,
Xenbase
Maeda,
Evaluation of the role of the retinal G protein-coupled receptor (RGR) in the vertebrate retina in vivo.
2003,
Pubmed
Mazroui,
Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression.
2002,
Pubmed
Mientjes,
Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo.
2004,
Pubmed
Miyashiro,
RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.
2003,
Pubmed
Morris,
Rearrangement of mRNAs for costamere proteins during costamere development in cultured skeletal muscle from chicken.
1994,
Pubmed
NULL,
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
1994,
Pubmed
O'Donnell,
A decade of molecular studies of fragile X syndrome.
2002,
Pubmed
Quadro,
Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein.
1999,
Pubmed
Siomi,
FXR1, an autosomal homolog of the fragile X mental retardation gene.
1995,
Pubmed
,
Xenbase
Siomi,
Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them.
1996,
Pubmed
Smolich,
Xenopus gamma-crystallin gene expression: evidence that the gamma-crystallin gene family is transcribed in lens and nonlens tissues.
1994,
Pubmed
,
Xenbase
Summerton,
Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems.
1997,
Pubmed
Summerton,
Morpholino antisense oligomers: design, preparation, and properties.
1997,
Pubmed
,
Xenbase
Summerton,
Morpholino antisense oligomers: the case for an RNase H-independent structural type.
1999,
Pubmed
Sutherland,
Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium.
1977,
Pubmed
Tucker,
Expression of three zebrafish orthologs of human FMR1-related genes and their phylogenetic relationships.
2004,
Pubmed
Vignali,
Xotx5b, a new member of the Otx gene family, may be involved in anterior and eye development in Xenopus laevis.
2000,
Pubmed
,
Xenbase
Warkman,
Amphibian cardiac troponin I gene's organization, developmental expression, and regulatory properties are different from its mammalian homologue.
2004,
Pubmed
,
Xenbase
Weiler,
Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses.
2004,
Pubmed
Youn,
Somitogenesis in the amphibian Xenopus laevis: scanning electron microscopic analysis of intrasomitic cellular arrangements during somite rotation.
1981,
Pubmed
,
Xenbase
Zhang,
The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2.
1995,
Pubmed
